Issues

Home > Issues (Page 26)

May 15, 2020 Innovation, Issues

Medical innovations do not happen overnight. Whether it is gene therapies, new vaccines, or cutting-edge medical equipment, developing innovative medical products is a risky venture. It also takes time, lots of financial resources, and most importantly, human ingenuity. Developing new drugs, for instance, can take between 10 and 15 years. Now, more than ever, it is imperative that our regulatory framework encourages innovation and protects the intellectual property that makes innovation possible. Otherwise, the medical advancements we desperately need will cease....

May 12, 2020 Blog, Coronavirus

Perhaps not since the Second World War has there been so much fear, anxiety, misery, and grief in this country. Many people are finding some measure of comfort by turning inward and using what amounts to a biological trick. How many times have you heard someone say to a person who is angry and agitated, “Hey, take a few deep breaths and chill.” Well, it works, and the reason has a physiological explanation. As does the popularity of the “mindfulness” phenomenon, which...

May 11, 2020 Coronavirus, Issues, Price and Costs, Value

There they go again. In the midst of the race for an effective COVID-19 treatment the Institute for Clinical and Economic Review (ICER) has performed an incomplete analysis of remdesivir in order to produce a cost estimate that is, by definition, precisely wrong. Remdesivir, produced by Gilead Sciences Inc., is an experimental antiviral medication that did not work as hoped to treat Hepatitis C, but is showing promise as a treatment for viruses such as SARS and COVID-19. If ICER’s analysis were...

May 11, 2020 Blog, Coronavirus

While many heroic doctors, nurses and other health care professionals are working long hours and risking their lives to treat COVID-19 patients, others have seen their workloads and hospital occupancy rates drop dramatically as a result of the coronavirus pandemic. This has created a financial crisis and endangered public health. At the onset of the COVID-19 outbreak, public health officials urged hospitals to suspend non-essential medical procedures. U.S. hospitals canceled tens of thousands of elective surgeries and other procedures, and urged...

May 8, 2020 Blog, Issues, Policy Proposals

It was not long ago that the economy’s rising tide was supporting state budgets across the country. As the Pew Charitable Trusts noted, widespread economic prosperity was supporting tax revenue growth and creating budget surpluses. When times are good, saving money is not always a priority in state capitols. But, times are no longer good, and saving money is now a top policy priority. The carnage is not contained to state budgets either. Businesses large and small are losing money, families are struggling...

May 1, 2020 Blog, Coronavirus

By Andrew I. Fillat and Henry I. Miller The headline, of course, is an aphorism dating from 1862 that was popularized by the charming 1992 Tom Hanks film, “Forrest Gump.” Stupid may be an innate characteristic, but dumbness is certainly an opportunity available to all. It can be especially surprising and sometimes infuriating when a person not thought to be stupid does some really dumb things. Back in college at our fraternity, we had an “award” for pledges who said or did dumb...

April 30, 2020 Blog, Coronavirus

Forcing a restructuring of the current pharmaceutical supply chain is a terrible idea. Yet, as a recent Wall Street Journal editorial exemplifies, there is growing support for this ill-considered policy. And, these proposals are not simply mere academic musings. The Trump Administration may implement an Executive Order that would turn this idea into actual policy. Congress, not to be outdone, is also considering several proposals that would force federal agencies to purchase drugs and medical supplies exclusively from U.S. suppliers. If implemented, these “Buy...

April 28, 2020 Blog, Coronavirus, Policy Proposals

On ‘Supply-Chain Repatriation,’ It’s Buyer (and Nation) Beware By Scott Lincicome One of the most fashionable COVID-19 proposals being circulated by Washington politicians and pundits these days is the “repatriating” of global supply chains for pharmaceuticals, medical devices, and “personal protective equipment” that have been “outsourced” over the past three decades, leaving America utterly dependent on foreign countries, especially China, for these essential products. Bringing that manufacturing back home, so the story goes, is the only way to ensure future “resiliency” in...

April 28, 2020 Coronavirus, Policy Proposals, Radio

PRI President, CEO, and Thomas W. Smith Fellow in Health Care Studies Sally C. Pipes joins PRI's Next Round podcast to discuss some of the health care challenges that have popped up during the coronavirus crisis, including a renewed push for single-payer and calls for prescription drug price controls and a “Buy America” mandate for drug manufacturing. We also discuss a few positives changes that have occurred despite these tough times – the rise of telehealth and the rolling back...

April 27, 2020 Coronavirus, Policy Proposals, Radio

Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to debate shelter-in-place rollbacks by states and European countries and why it could be too early. Miller and Larson also debate the approaches of other countries and how their infection and death rate compare to the United States. Dr. Miller's segment begins at the 47:00 minute mark.  Lars Larson National Podcast · Lars Larson National Podcast 04-21-20...

April 27, 2020 Blog, Coronavirus, Policy Proposals

The presidential campaign of Sen. Bernie Sanders, I-Vt., may have ended, but his "Medicare-for-all" crusade marches on. Writing in The New York Times last week, Sanders argued that the coronavirus outbreak proved the government should take over our nation's health care system. Sanders isn't the only one championing "Medicare-for-all" in the wake of the pandemic. More than half of voters now say they support a single-payer system. But "Medicare-for-all" would not have improved our nation's response to the outbreak. Other countries with socialized medicine have struggled mightily to combat COVID-19. In fact, the United States would have been even...

April 27, 2020 Blog, Coronavirus, Innovation

How hydroxychloroquine toes the line between promise and 'happy talk' in the coronavirus fight By: Anjalee Khemlani After weeks of polarizing debate over the use of two generic anti-malarial drugs, hydroxychloroquine and chloroquine, the Food and Drug Administration this week warned they were not “safe and effective” when used on COVID-19 patients. However, the hydroxychloroquine debate is far from over, as the drug gets qualified support from others deeply involved in the war against the coronavirus, and is used to treat COVID-19 patients...

April 22, 2020 Blog, Coronavirus, Innovation

Covid-19 cases, hospitalizations and deaths are leveling off in hot spots like Seattle and New York. New infections should soon begin to decline, and many parts of the country will be able to start a phased return to “normal.” Yet without a vaccine, normality will look very different than it did before the pandemic. The medical community and the public are hungry for news about vaccines, but accounts of progress have been exaggerated. Anthony Fauci, director of the National Institute of...

April 21, 2020 Blog, Coronavirus, Policy Proposals

Dr. Oz and other TV docs hit with new coronavirus symptom: tripping over their own tongues By Corky Siemaszko Three of America's best known TV doctors are taking their medicine after making inflammatory statements about the coronavirus. . . . . . Dr. Henry I. Miller, a former federal Food and Drug Administration researcher and a senior fellow at the Pacific Research Institute in San Francisco, said they are ubiquitous on television because the medium is looking for "pseudo-experts" who reflect the biases of...

April 21, 2020 Briefs, Price and Costs

Expanding “Buy America” rules for prescription drugs and medical supplies would reduce patient access to drugs and further damage the economy, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to download the brief “As the U.S. fights the coronavirus, policymakers must ensure that life-saving drugs are readily available to America’s patients,” said Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Studies and the...

April 20, 2020 Blog, Coronavirus, Policy Proposals, Radio

Dr. Henry Miller joins the John Batchelor Show to provide an update on the state of testing in the United States and rest of the world. Dr. Miller explains that antibody testing will determine the true amount of cases, and also explains that only reliable, largely-used tests will help in the fight against the coronavirus. Dr. Miller also explains the danger of inaccurate and bad testing, like a recent example from the United Kingdom where their recent antibody tests were...

April 16, 2020 Blog, Coronavirus, Policy Proposals

President Trump announced at the White House coronavirus press briefing on Tuesday that the United States will immediately halt all funding for the World Health Organization, because it had caused "so much death" by "severely mismanaging and covering up" the coronavirus' spread, putting "political correctness over lifesaving measures." Other government officials, health experts, and analysts also have raised concerns about the WHO’s bungled response to the pandemic, accusing it of being too trusting of the Chinese government, which initially tried to conceal the outbreak in Wuhan. Rather than taking Beijing to...

April 14, 2020 Blog, Coronavirus, Policy Proposals

The coronavirus pandemic is threatening to stretch many hospitals to their breaking point. Beds are filling up with stricken patients, and public health officials are concerned about whether we'll have enough doctors and other healthcare professionals to care for them. So they're scrambling to roll back years' worth of regulations on the healthcare labor market—many of which never should've been in place to begin with. There's no shortage of red tape for policymakers to cut to boost the supply of care...

April 13, 2020 Blog, Coronavirus

Bill Gates announced on April 2 that his foundation would fund the construction of facilities to produce seven possible coronavirus vaccines. The Microsoft founder acknowledges that only two of those vaccines will likely succeed – and the foundation will thus waste billions of dollars on the failed candidates. That's a small price to pay to ensure the prompt delivery of vaccines, save countless lives and restart the economy, he says. And yet, "Billionaires should not exist," according to Sen. Bernie Sanders. "Every...